Search results
Showing 3631 to 3645 of 8238 results
The appeal panel is drawn from a group of people approved by the Secretary of State for Health and Social Care to hear appeals.
Past technology appraisal appeals and decisions
A timeline showing where in the NICE evaluation process companies will be charged.
A step-by-step summary about how we develop our technology appraisal guidance.
Technology appraisal and highly specialised technologies appeals
Learn about the NICE Technology Appraisal and Highly Specialised Technologies appeals process, including how decisions are made, the criteria for appeals, and the role of the appeal panel in ensuring fair and transparent evaluations of health technologies.
Fees for technology appraisals and highly specialised technologies
NICE fees for technology appraisals and highly specialised technologies
NICE's technology appraisal guidance makes recommendations on the use of new and existing medicines and other treatments within the NHS.
Clarification on demonstrating patient access to medicines and treatments recommended by NICE Technology Appraisal (TA) or Highly Specialised Technologies (HST) guidance.
NICE has a key role in UK licensing and the evaluation of and access to new and innovative products for the health system.
Home What NICE does Our guidance About technology appraisal guidance {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":
Data on the cancer recommendations made by our technology appraisal programme. Includes information on the number of positive recommendations we've made.
Data on the recommendations made by our technology appraisal programme. Includes information on the number of positive recommendations we've made.
Home What NICE does Our guidance About technology appraisal guidance Our methods and processes (health technology evaluation manual)...
Technology appraisal submission templates and supporting documents
All the templates and supporting documents you need to make a technology appraisals submission with NICE.
Decision aid for Intrabeam radiotherapy system for adjuvant treatment of early breast cancer, TA501 c NICE 2018. All rights reserved. Subject to...